Medical Developments International has released a press release.
Security Class Reinstatement to Quotation MVPO
Filed with ASX ·
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
Story so far
Earlier from Medical Developments International
- Completion of Retail Entitlement Offer
- FY222 Full Year Results Investor Presentation
- MVP Announces FY22 Full Year Results
- FY22 Full Year Accounts
- Security Class Suspension from Quotation MVPO
Later from Medical Developments International
- Chair and CEO Presentation to Shareholders
- China Clinical Trials Discontinued
- 2023 Half Year ASX Announcement
- 2023 Half Year Report (including 4D)
- 2023 Half Year Presentation
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International